BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23024058)

  • 21. Association of polymorphisms in the ICOS and ICOSL genes with the pathogenesis of autoimmune thyroid diseases.
    Yoshie N; Watanabe M; Inoue N; Kawaguchi H; Hidaka Y; Iwatani Y
    Endocr J; 2016; 63(1):61-8. PubMed ID: 26560438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.
    Wiendl H; Mitsdoerffer M; Schneider D; Melms A; Lochmuller H; Hohlfeld R; Weller M
    Brain; 2003 May; 126(Pt 5):1026-35. PubMed ID: 12690043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.
    Arakawa H; Jinnin M; Muchemwa FC; Makino T; Kajihara I; Makino K; Honda N; Sakai K; Fukushima S; Ihn H
    Exp Dermatol; 2011 Sep; 20(9):764-6. PubMed ID: 21615510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
    Wang F; Yan T; Chen L; Chen X; Liu T; Shen S; Li T; Gao L; Wang T; Sun J; Liu C; Wu H; Zhang X; Chen L
    J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
    Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
    Front Immunol; 2022; 13():992614. PubMed ID: 36119089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
    Hamel KM; Cao Y; Olalekan SA; Finnegan A
    Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
    Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
    Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis.
    Okamoto T; Saito S; Yamanaka H; Tomatsu T; Kamatani N; Ogiuchi H; Uchiyama T; Yagi J
    J Rheumatol; 2003 Jun; 30(6):1157-63. PubMed ID: 12784384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repressor of GATA-3 can negatively regulate the expression of T cell cytokines through modulation on inducible costimulator.
    Zang YS; Fang Z; Liu YA; Li B; Xiu QY
    Chin Med J (Engl); 2012 Jun; 125(12):2188-94. PubMed ID: 22884151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.
    Watanabe M; Takagi Y; Kotani M; Hara Y; Inamine A; Hayashi K; Ogawa S; Takeda K; Tanabe K; Abe R
    J Immunol; 2008 Apr; 180(8):5222-34. PubMed ID: 18390703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
    Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
    Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; AirĂ² P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients.
    Zhan XK; Liu XK; Zhang S; Chen H
    Animal Model Exp Med; 2023 Oct; 6(5):464-473. PubMed ID: 37850501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T helper 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of inducible T-cell costimulator.
    Jiao Q; Qian Q; Liu C; Luo Y; Fang F; Wang M; Ji J; Qian H; Zhang X; Maurer M
    Br J Dermatol; 2020 Mar; 182(3):648-657. PubMed ID: 31090221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
    Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
    Front Immunol; 2021; 12():786680. PubMed ID: 34925367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.